Amir Ali Rahsepar1, Laleh Golestanirad2, Hassan Haji-Valizadeh3, Haris Saybasili 1, Julie A Blaisdell 1, Michael Markl3, John Kirsch4, James C Carr1, and Jeremy D Collins1
1Department of Radiology, Northwestern University, Chicago, IL, United States, 2Athinoula A. Martinos Center for Biomedical Imaging, Boston, MA, United States, 3Department of Biomedical Engineering, McCormick School of Engineering, Chicago, IL, United States, 4Siemens Medical Solutions, Boston, MA, United States
Synopsis
Although SAR value is an
important factor in device heating, but this study also provides information about the other factors like the total amount of
delivered RF energy, time period of RF delivery and most importantly the pause
between pulse sequences should be considered
Introduction
MRI
is considered the imaging modality of choice in many clinical situations. Unfortunately,
MRI is currently contraindicated for a large number of patients who have
implanted devices such as pacemakers, deep brain stimulators. Considering the
advancing age of the population, increasing number of patients with implanted
devices, and increasing availability of MRI, there will be increasing demand to
use the diagnostic power of MRI in this patient group. The main associated risks with performing MRI arise from
the interaction between the implanted device system and electromagnetic energy
deposition. Radiofrequency energy absorption may lead to heating in biologic
tissue (1). Moreover, presence of conductive implants in the body raises the
concern of RF heating in leads and tissues surrounding such devices. Thermal
injury and the subsequent formation of fibrosis may result in increasing
capture thresholds, and deterioration of device function (2). Specific
absorption rate (SAR), is the
dosimetric term used to characterize the thermogenic aspects of the
electromagnetic field. Since a single SAR measure cannot sufficiently predict
device heating, specific energy dose (SED) defined as the amount of RF energy
deposited in an object has also been used. Based on the previous studies, whole
body SAR is not very well-associated with the risk to patients with implanted
devices, thus in this large study, we aimed to determine the average whole body
and local SAR and SED values in patients undergoing different types of MRI
exams as a first step to inform risks to patients in the MRI environment.Methods
In
this retrospective IRB approved study, log files from 22,421 MRI scans performed
on 1.5 and 3T scanners (Avanto, Skyra, Siemens, Erlangen, Germany) at our
institution between September 2015 and September 2016 were recorded and SAR and
SED for 1,076,938 pulse sequences were extracted from these log files. We
obtained the MRI scanned region through a query of the enterprise data
warehouse at Northwestern Memorial Hospital for the entire study period,
successfully matching the scanned region with 14,153 log files. The log-file
for each patient was comprehensively parsed to extract SAR, SED, and scan
duration times and the pause between each sequence. In the log files, whole
body and local SAR values were calculated for 10 and 360 second intervals. For
3T scanners, local SAR values were calculated for head, torso and leg regions. Due
to non-normally distributed data based on Kolmogorov–Smirnov testing, results
are presented as a median with interquartile ranges (IQR).Results
Generally, 3T scans had higher SAR and SED values
compared with 1.5T scans when comparing the same region of scan between two
scanners (p<0.001) (Table 1). The
length of each pulse sequence in 3T scanners were shorter and thus the length
of the MRI study was shorter. MRI of the thoracic and lumbar spine had the
highest SAR and SED values compared with other types of MRI scans (Table 2). The
average whole body SAR value simulated for 360 and 10 seconds have been
summarized for different types of MRI scan (Table 2). On Average, between each
sequence there was a 12 second pause. Total paused time for different types of
MRI scan was about 20%±5% of total length of MRI scan, however, for cardiac
MRI, the total length of MRI was similar to the total dead time (Table 2). Analysis
of the local SAR showed that during lower extremity MRI studies rate of RF
energy deposition in the torso is 50% of the rate of RF energy delivered in
lower limb. Discussion
Our findings provide a comprehensive insight into
the expected RF-exposure seen across a variety of routine clinical exams and
can be used in numerical simulations that aim to predict clinically relevant device
heating. The large number of subjects enrolled in this study provides a realistic
time interval between each sequence and thus implanted device heating/cooling
can be evaluated more accurately. Although SAR value is an important factor in
device heating, other factors like the total amount of delivered RF energy,
time period of RF delivery and most importantly the pause between pulse
sequences should be considered (2). Estimating the exact amount of regional SAR
and SED on different implanted devices during different type of MRI scans would
provide more information for physicians and MRI technologists to perform MRI
safely in patients with implanted devices.Conclusion
Our results provide a comprehensive insight into the
expected RF-exposure seen across a variety of routine clinical exams. Educating
physicians and MRI techs regarding these values may assist with protocol
optimization and investigating device-related complications occurring during or
after an MRI exam.Acknowledgements
No acknowledgement found.References
(1) Roguin A, Zviman MM, Meininger GR, Rodrigues ER,
Dickfeld TM, Bluemke DA, et al. Modern pacemaker and implantable cardioverter/defibrillator
systems can be magnetic resonance imaging safe: in vitro and in vivo assessment
of safety and function at 1.5 T. Circulation 2004 Aug 3;110(5):475-82.
(2) Nazarian S, Roguin A, Zviman MM, Lardo AC,
Dickfeld TL, Calkins H, et al. Clinical utility and safety of a protocol for
noncardiac and cardiac magnetic resonance imaging of patients with permanent
pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.
Circulation 2006 Sep 19;114(12):1277-84.